Global Peptide Therapeutics Market Estimated to Reach USD 42.5 Billion by 2026

23-Mar-2020 | Facts and Factors

Findings from Facts and Factors report “Peptide Therapeutics Market By Route of Administration (Parenteral Route, Oral Route, Pulmonary, Mucosal, and Others), By Type (Generic and Innovative), By Synthesis Technology (Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS), and Hybrid Technology), By Type of Manufacturers (In-house and Outsourced), By Application (Cancer, Metabolic, Cardiovascular Disorder, Respiratory, GIT, Anti-infection, Pain, Dermatology, CNS, Renal, and Others), and By Region: Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026” states that the global Peptide Therapeutics market in 2019 was approximately over USD 24 Billion. The market is expected to grow at a CAGR of around 8.5% and is anticipated to reach around USD 42.5 Billion by 2026.

Peptides are formed by combing two or more amino acid monomers using amide bonds. The peptides attach to the specific cell surface receptors to help treat diseases. The peptides were earlier used in diagnostics and hormonal therapy but now it has extensive therapeutic applications of cancer and chronic metabolic diseases.

Browse the full “Peptide Therapeutics Market By Route of Administration (Parenteral Route, Oral Route, Pulmonary, Mucosal, and Others), By Type (Generic and Innovative), By Synthesis Technology (Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS), and Hybrid Technology), By Type of Manufacturers (In-house and Outsourced), By Application (Cancer, Metabolic, Cardiovascular Disorder, Respiratory, GIT, Anti-infection, Pain, Dermatology, CNS, Renal, and Others), and By Region: Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026" report at https://www.fnfresearch.com/global-peptide-therapeutics-market-by-route-of-administration-868

Market Drivers:

The growth factor for the demand of the peptide-based therapeutics is the sedentary lifestyle and unhealthy diet that has increased the occurrences of chronic diseases. Furthermore, the growing geriatric population which is prone to various chronic conditions is anticipated to fuel the growth of the global Peptide Therapeutics market. The increasing incidences of cancer and the adverse effects of chemotherapy or radiotherapies help increase the demand for the peptide therapeutics across the globe. Apart from this, the technological advancements and adoption of hybrid technologies help lower costs of peptide therapeutics. The high efficiency and low side effects are the major reason for its high prescription rate. However, the high expenditure on the discovery and development of new therapeutics, off-patent concept, presence of generic or biosimilar peptide therapeutic drugs are likely to hamper the valuation of global Peptide Therapeutics market.

Market Segment Dominance:

• Innovative peptides held the majority of the market size

The innovative peptides are estimated to dominate the market due to the high funding by large pharmaceuticals in R&D activities and research for the manufacturing of new drugs coupled with the soaring prescription rate.

• In-house manufacturing is projected to lead the global Peptide Therapeutics market

The in-house manufacturing category accounts for the largest share owing to the escalating stringent government regulations and high outsourcing costs involved in the production of peptide therapeutics. The increasing preference of in-house manufacturing by large pharmaceutical companies due to the presence of proper infrastructure for massive production and advanced technology will help surge the market growth.

• The parenteral route is anticipated to dominate the market

Parenteral route of administration is projected to dominate the global Peptide Therapeutics market. The reason for the supremacy of this route of administration is its quicker delivery of drugs, ease in application, and increasing adoption rate.

• LPPS category exhibits the highest market share in the Peptide Therapeutics market

The LPPS technology is expected to project a large market share on a global level due to the rising demand for pure peptides to develop highly efficient and durable therapeutics.

• Cancer category led the global Peptide Therapeutics market

The increasing incidences of cancer owing to the unhealthy diet and sedentary lifestyle are the major factor booming the demand for peptide therapeutics. In addition to this, the high requirement for competent and rapid-acting therapeutics, awareness about the adverse effects of chemotherapy and radiation therapy is one of the rendering factors for the growth of the market.

Regional Dominance:

• North America is expected to lead the global Peptide Therapeutics market

North America held the majority of the market share of the global Peptide Therapeutics market in 2018. The dominance of the market in this region is attributed to the growing awareness regarding peptide therapeutics products, high demand for diagnostics in cancer & other diseases, and advancements in the biotechnology industry. Moreover, the escalating R&D spending by the government will also aid in the development of peptide therapeutics in the coming years.

Report Scope

Key Players:

Some of the major market players in the global Peptide Therapeutics market include Novartis AG, Eli Lilly and Company, Amgen, Inc., Pfizer, Inc., Lonza Inc., Teva Pharmaceuticals Industries Ltd., Sanofi, GlaxoSmithKline plc., Bristol-Myers Squibb, AstraZeneca PLC, Takeda Pharmaceutical Company Limited, and Novo Nordisk A/S.

This report segments the global Peptide Therapeutics market as follows:

Global Peptide Therapeutics Market: Type Outlook Segmentation Analysis

• Generic
• Innovative

Global Peptide Therapeutics Market: Type of Manufacturers Outlook Segmentation Analysis

• In-house
• Outsourced

Global Peptide Therapeutics Market: Route of Administration Outlook Segmentation Analysis

• Parenteral Route
• Oral Route
• Pulmonary
• Mucosal
• Others

Global Peptide Therapeutics Market: Synthesis Technology Segmentation Analysis

• Solid Phase Peptide Synthesis (SPPS)
• Liquid Phase Peptide Synthesis (LPPS)
• Hybrid Technology

Global Peptide Therapeutics Market: Application Segmentation Analysis

• Metabolic
• Cardiovascular Disorder
• Respiratory
• GIT
• Anti-infection
• Pain
• Dermatology
• CNS
• Renal
• Cancer
• Others

Global Market: Regional Segmentation Analysis

• North America
  • The U.S.
  • Canada
• Europe
  • Germany
  • The UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Contact Us:

Facts & Factors

Global Headquarters

Level 8, International Finance Center, Tower 2,
8 Century Avenue, Shanghai,
Postal - 200120, China
Tel: +86 21 80360450

Email: [email protected]

Web: https://www.fnfresearch.com